Endocytosis in cellular uptake of drug delivery vectors: Molecular aspects in drug development

Bioorg Med Chem. 2020 Sep 15;28(18):115556. doi: 10.1016/j.bmc.2020.115556. Epub 2020 Jul 18.

Abstract

Drug delivery vectors are widely applied to increase drug efficacy while reducing the side effects and potential toxicity of a drug. They allow for patient-tailored therapy, dose titration, and therapeutic drug monitoring. A major part of drug delivery systems makes use of large nanocarriers: liposomes or virus-like particles (VLPs). These systems allow for a relatively large amount of cargo with good stability of vectors, and they offer multiple options for targeting vectors in vivo. Here we discuss endocytic pathways that are available for drug delivery by large nanocarriers. We focus on molecular aspects of the process, including an overview of potential molecular targets for studies of drug delivery vectors and for future solutions allowing targeted drug delivery.

Keywords: Bacteriophages; Drug delivery; Endocytosis; Liposomes; Viral vectors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport
  • Biomarkers / metabolism
  • Delayed-Action Preparations / chemistry*
  • Delayed-Action Preparations / metabolism
  • Drug Compounding
  • Endocytosis / drug effects*
  • Humans
  • Liposomes / chemistry
  • Molecular Targeted Therapy
  • Nanocapsules / chemistry*
  • Particle Size
  • Polymers / chemistry

Substances

  • Biomarkers
  • Delayed-Action Preparations
  • Liposomes
  • Nanocapsules
  • Polymers